Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Paramount Gold Nevada Corp.PZG · Entity 9016 | 10% owner | June 13, 2025 | June 18, 2025 |
| VACCINEX, INC.VCNX · Entity 9673 | Director · 10% owner | November 14, 2024 | November 18, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Paramount Gold Nevada Corp.
Report date June 13, 2025 · Filed June 18, 2025
Jointly reported with FCMI Parent Co., Buckingham Charitable Foundation
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 9,692,310 |
Reported balance
After 2025-06-13 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-06-13 · Purchase · Acquired 416,000 · Balance 9,692,310 F1: Of such 9,692,310 shares, 5,791,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by the Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg. |
Filing footnotes · ownership attribution and instrument terms
F1: Of such 9,692,310 shares, 5,791,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by the Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg.
VACCINEX, INC.
Report date November 14, 2024 · Filed November 18, 2024
Jointly reported with FCMI Parent Co.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy FCMI Parent Co. | 1,051,389 |
Reported balance
After 2024-11-14 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-11-14 · Grant · Acquired 30,756 · Balance 1,051,389 F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy FCMI Parent Co. | 584,646 |
Reported balance
After 2024-11-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-11-14 · Grant · Acquired 584,646 · Balance 584,646 F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full. F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.64 · Expires 2029-09-18 | IndirectBy FCMI Parent Co. | 653,210 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 653,210 F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy FCMI Parent Co. | 102,960 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 102,960 F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full. F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy FCMI Parent Co. | 92,504 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 92,504 F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full. F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 2,094 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,094 |
| Common StockSEC Table I · non-derivative | IndirectBy Pan Atlantic Holdings Ltd. | 180 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 180 F1: Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Friedberg Global-Macro Hedge Fund Ltd. | 16,724 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 16,724 F2: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2025 Filed Jun 18, 2025 16:30 UTC | Paramount Gold Nevada Corp. PZG · Entity 9016 | PurchaseCommon Stock, par value $0.01 per share | 416,000 | $0.60 | $249,600.00 |
DisclosureSEC source: 0001213900-25-055670 · ownership.xml · nonDerivative · entry 1 FCMI Parent Co. · CIK 0001678258 · 10% owner Buckingham Charitable Foundation · CIK 0001977540 · 10% owner FRIEDBERG ALBERT · CIK 0001268239 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,692,310 F1 · ownership.direct: Of such 9,692,310 shares, 5,791,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by the Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 16:06 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantWarrant (Right to Buy) · Derivative | 584,646 | $3.25 Strike: $0.00 | $1,900,041.04 |
DisclosureSEC source: 0001062993-24-019266 · form4.xml · derivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 584,646 Underlying: Common Stock · 584,646 shares Expires not disclosed F4 · derivative.exercise_date: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full. F4 · derivative.expiration_date: These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 16:06 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantCommon Stock | 30,756 | $3.25 | $99,957.00 |
DisclosureSEC source: 0001062993-24-019266 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 1,051,389 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 16:11 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantWarrant (Right to Buy) · Derivative | 653,210 | $0.13 Strike: $5.64 | $81,651.25 |
DisclosureSEC source: 0001062993-24-016838 · form4.xml · derivative · entry 8 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 653,210 Underlying: Common Stock · 653,210 shares Expires 2029-09-18 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 16:11 UTC | VACCINEX, INC. VCNX · Entity 9673 | Exercise / conversionWarrant (Right to Buy) · Derivative | 25,723 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016838 · form4.xml · derivative · entry 7 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 92,504 Underlying: Common Stock · 25,723 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. FCMI partially exercised this warrant for 25,723 shares at an exercise price of $5.636 per share and pre-funded the remaining 92,504 shares at a price of $5.635. The exercise price for the remaining 92,504 shares underlying this warrant was subsequently adjusted to $0.001. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 16:11 UTC | VACCINEX, INC. VCNX · Entity 9673 | Exercise / conversionWarrant (Right to Buy) · Derivative | 214,286 | $0.00 Strike: $5.64 | $0.00 |
DisclosureSEC source: 0001062993-24-016838 · form4.xml · derivative · entry 6 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 0 Underlying: Common Stock · 214,286 shares Expires 2028-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to a warrant inducement agreement by and between the issuer and FCMI dated September 17, 2024 (the "Warrant Inducement Agreement"), the exercise price of this warrant was adjusted to $5.636. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 16:11 UTC | VACCINEX, INC. VCNX · Entity 9673 | Exercise / conversionCommon Stock | 25,723 | $5.64 | $144,974.83 |
DisclosureSEC source: 0001062993-24-016838 · form4.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 1,020,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. FCMI partially exercised this warrant for 25,723 shares at an exercise price of $5.636 per share and pre-funded the remaining 92,504 shares at a price of $5.635. The exercise price for the remaining 92,504 shares underlying this warrant was subsequently adjusted to $0.001. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 16:11 UTC | VACCINEX, INC. VCNX · Entity 9673 | Exercise / conversionCommon Stock | 214,286 | $5.64 | $1,207,715.90 |
DisclosureSEC source: 0001062993-24-016838 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 994,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to a warrant inducement agreement by and between the issuer and FCMI dated September 17, 2024 (the "Warrant Inducement Agreement"), the exercise price of this warrant was adjusted to $5.636. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. ("FCMI") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 16:30 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 100 | $4.51 | $451.00 |
DisclosureSEC source: 0001062993-24-014976 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 780,624 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 16:04 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 2,753 | $4.92 | $13,544.76 |
DisclosureSEC source: 0001062993-24-014577 · form4.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 780,524 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 16:04 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 3,653 | $4.60 | $16,803.80 |
DisclosureSEC source: 0001062993-24-014577 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 777,771 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 01, 2024 Filed Aug 2, 2024 16:05 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 11,703 | $4.72 | $55,238.16 |
DisclosureSEC source: 0001062993-24-014364 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 774,118 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 16:05 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 16,128 | $7.40 | $119,282.69 |
DisclosureSEC source: 0001062993-24-014289 · form4.xml · nonDerivative · entry 6 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 762,415 F6 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 to $7.40, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 16:05 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 83,243 | $6.41 | $533,587.63 |
DisclosureSEC source: 0001062993-24-014289 · form4.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 746,287 F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.11 to $7.06, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 16:05 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 100,629 | $5.74 | $577,409.20 |
DisclosureSEC source: 0001062993-24-014289 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 663,044 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $6.10, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 30, 2024 Filed May 31, 2024 16:31 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 861 | $5.20 | $4,472.90 |
DisclosureSEC source: 0001062993-24-011556 · form4.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 562,415 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.20. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 29, 2024 Filed May 31, 2024 16:31 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 957 | $4.95 | $4,737.15 |
DisclosureSEC source: 0001062993-24-011556 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 561,554 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| April 19, 2024 Filed Apr 22, 2024 16:33 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 282 | $4.73 | $1,333.86 |
DisclosureSEC source: 0001062993-24-008643 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 560,597 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 20:53 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantWarrant (Right to Buy) · Derivative | 102,960 | $7.77 Strike: $7.64 | $799,999.20 |
DisclosureSEC source: 0001062993-24-007660 · form4.xml · derivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 102,960 Underlying: Common Stock · 102,960 shares Expires 2029-03-28 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 20:53 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantCommon Stock | 102,960 | $7.77 | $799,999.20 |
DisclosureSEC source: 0001062993-24-007660 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 560,315 F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 16:32 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantWarrant (Right to Buy) · Derivative | 1,655,172 | $0.73 Strike: $1.00 | $1,199,999.70 |
DisclosureSEC source: 0001062993-24-002769 · form4.xml · derivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 1,655,172 Underlying: Common Stock · 1,655,172 shares Expires 2029-02-08 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 16:32 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantCommon Stock | 1,655,172 | $0.73 | $1,199,999.70 |
DisclosureSEC source: 0001062993-24-002769 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 6,402,966 F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 03, 2023 Filed Oct 5, 2023 16:30 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseWarrant (Right to Buy) · Derivative | 3,000,000 | $1.00 Strike: $1.00 | $3,000,000.00 |
DisclosureSEC source: 0001062993-23-019061 · form4.xml · derivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2028-10-03 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 03, 2023 Filed Oct 5, 2023 16:30 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 3,000,000 | $1.00 | $3,000,000.00 |
DisclosureSEC source: 0001062993-23-019061 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 4,747,794 F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 15, 2023 Filed May 16, 2023 16:33 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantCommon Stock | 6,711,552 | $0.37 | $2,512,133.91 |
DisclosureSEC source: 0001062993-23-011230 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 26,216,904 F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 10, 2023 Filed May 12, 2023 13:23 UTC | Paramount Gold Nevada Corp. PZG · Entity 9016 | PurchaseCommon Stock, par value $0.01 per share | 4,300,000 | $0.32 | $1,376,000.00 |
DisclosureSEC source: 0001019056-23-000244 · paramount.xml · nonDerivative · entry 1 FCMI Parent Co. · CIK 0001678258 · 10% owner Buckingham Charitable Foundation · CIK 0001977540 · 10% owner FRIEDBERG ALBERT · CIK 0001268239 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,276,310 F1 · ownership.direct: Of such 9,276,310 shares, 5,375,000 shares are owned directly by FCMI Parent Co., and 3,901,310 shares are owned directly by The Buckingham Charitable Foundation. The Buckingham Charitable Foundation is a Canadian Registered Charity of which Albert Friedberg is a Trustee. All the shares purchased in Table I were purchased directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 16:34 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantCommon Stock | 4,146,341 | $0.41 | $1,699,999.81 |
DisclosureSEC source: 0001062993-23-008323 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 19,505,352 F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| November 23, 2022 Filed Nov 28, 2022 16:35 UTC | VACCINEX, INC. VCNX · Entity 9673 | GrantCommon Stock | 3,778,575 | $0.53 | $1,999,999.75 |
DisclosureSEC source: 0001062993-22-022816 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 15,359,011 F4 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F4 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 16:24 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 1,801,801 | $1.11 | $1,999,999.11 |
DisclosureSEC source: 0001062993-22-001867 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 11,580,436 F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F4 · balance_after: Includes 967,983 shares previously reported as being held indirectly through FCMI Financial Corporation. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 16:24 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 1,801,801 | $1.11 | $1,999,999.11 |
DisclosureSEC source: 0001062993-22-001867 · form4.xml · nonDerivative · entry 3 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Friedberg Global-Macro Hedge Fund Ltd. Disclosed balance after: 3,511,894 F2 · shares: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F2 · balance_after: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F2 · ownership.nature: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC | VACCINEX, INC. VCNX · Entity 9673 | ConversionOption (Right to Acquire) · Derivative | 9,679,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · derivative · entry 7 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Financial Corporation Disclosed balance after: 0 Underlying: Common Stock · 967,983 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F6 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F6 · derivative.exercise_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F6 · derivative.expiration_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F4 · ownership.nature: FCMI Financial Corp. is a wholly-owned subsidiary of FCMI Parent Co. Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC | VACCINEX, INC. VCNX · Entity 9673 | ConversionOption (Right to Acquire) · Derivative | 21,475,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · derivative · entry 6 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 0 Underlying: Common Stock · 1,180,051 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F5 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F5 · derivative.exercise_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F5 · derivative.expiration_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC | VACCINEX, INC. VCNX · Entity 9673 | ConversionCommon Stock | 967,983 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Financial Corporation Disclosed balance after: 967,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F4 · ownership.nature: FCMI Financial Corp. is a wholly-owned subsidiary of FCMI Parent Co. Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC | VACCINEX, INC. VCNX · Entity 9673 | ConversionCommon Stock | 1,180,051 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 8,810,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 10, 2020 Filed Jul 10, 2020 16:18 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 1,126,760 | $3.55 | $3,999,998.00 |
DisclosureSEC source: 0000891839-20-000208 · edgar.xml · nonDerivative · entry 3 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Friedberg Global-Macro Hedge Fund Ltd. Disclosed balance after: 1,710,093 F2 · ownership.nature: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 16:15 UTC | Paramount Gold Nevada Corp. PZG · Entity 9016 | OtherWarrants to purchase Common Stock · Derivative | 380,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001019056-20-000414 · paramount.xml · derivative · entry 2 FCMI Parent Co. · CIK 0001678258 · 10% owner FCMI FINANCIAL CORP ET AL · CIK 0000931301 · 10% owner FRIEDBERG ALBERT · CIK 0001268239 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 190,000 shares Expires 2020-07-10 F2 · kind: On July 10, 2020, the Warrants described in Table II expired in accordance with their terms. No consideration was paid to FCMI Parent Co. upon expiration of the Warrants. F2 · price: On July 10, 2020, the Warrants described in Table II expired in accordance with their terms. No consideration was paid to FCMI Parent Co. upon expiration of the Warrants. F1 · ownership.direct: Of such 4,976,310 shares, 3,754,099 shares are owned directly by FCMI Parent Co., and 1,222,211 shares are owned directly by FCMI Financial Corporation. FCMI Financial Corporation is a wholly-owned subsidiary of FCMI Parent Co. All of the Warrants reported as expired in Table II were owned directly by FCMI Parent Co. Mr. Albert D. Friedberg is the President of FCMI Parent Co., which is owned by Mr. Friedberg and members of his family and controlled by Mr. Friedberg. F2 · ownership.direct: On July 10, 2020, the Warrants described in Table II expired in accordance with their terms. No consideration was paid to FCMI Parent Co. upon expiration of the Warrants. Read SEC document |
| March 30, 2020 Filed Mar 30, 2020 17:20 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 5,000 | $4.06 | $20,300.00 |
DisclosureSEC source: 0000891839-20-000084 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,630,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 17:20 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 4,000 | $4.18 | $16,720.00 |
DisclosureSEC source: 0000891839-20-000084 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,625,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 26, 2020 Filed Mar 26, 2020 18:08 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 1,000 | $4.44 | $4,440.00 |
DisclosureSEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,621,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 18:08 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 2,000 | $4.40 | $8,800.00 |
DisclosureSEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,620,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 17:24 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 2,000 | $4.31 | $8,620.00 |
DisclosureSEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,618,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 17:24 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 4,000 | $4.15 | $16,600.00 |
DisclosureSEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,616,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 20:05 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 3,440 | $4.00 | $13,760.00 |
DisclosureSEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 6 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,612,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:05 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 600 | $4.15 | $2,490.00 |
DisclosureSEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,609,161 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:05 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 3,000 | $4.28 | $12,840.00 |
DisclosureSEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,608,561 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 17:09 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 4,000 | $4.20 | $16,800.00 |
DisclosureSEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,605,561 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 17:09 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 231 | $4.22 | $974.82 |
DisclosureSEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,601,561 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 16:25 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 982,318 | $5.09 | $4,999,998.62 |
DisclosureSEC source: 0000891839-20-000034 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,601,330 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 16:30 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 1,838,235 | $4.08 | $7,499,998.80 |
DisclosureSEC source: 0000891839-19-000142 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 6,619,012 F3 · balance_after: This Form 4 corrects a prior inadvertent administrative error as to the total beneficial ownership reported. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 26, 2019 Filed Jul 29, 2019 16:37 UTC | VACCINEX, INC. VCNX · Entity 9673 | PurchaseCommon Stock | 1,000 | $3.99 | $3,990.00 |
DisclosureSEC source: 0000891839-19-000134 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 4,791,521 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.